What are the recommended vitamin B12 (cobalamin) intramuscular injection regimens and the target serum B12 concentration to achieve and maintain?

Vitamin B12 Injection Guidelines

For patients with confirmed B12 deficiency due to malabsorption, administer hydroxocobalamin 1 mg intramuscularly three times weekly for 2 weeks if no neurological symptoms are present, or on alternate days until neurological improvement plateaus if neurological involvement exists, then transition to lifelong maintenance injections every 2–3 months. 1

Target Serum B12 Levels

Do not use serum B12 levels to guide injection frequency or determine when to stop therapy. 1, 2 The goal is clinical symptom resolution and normalization of functional biomarkers, not achieving a specific serum B12 number. 1

Optimal Target Ranges

• Serum B12 should be maintained above 300 pmol/L (approximately 400 pg/mL) for optimal health outcomes 3
• Target homocysteine <10 μmol/L for cardiovascular protection 1
• Target methylmalonic acid (MMA) <271 nmol/L to confirm functional adequacy 1, 3

Initial Treatment Protocols

Patients WITH Neurological Symptoms

Hydroxocobalamin 1 mg intramuscularly on alternate days until no further neurological improvement (typically requiring several weeks to months), then transition to maintenance of 1 mg IM every 2 months for life. 1, 4

Neurological manifestations include:

• Peripheral neuropathy, paresthesias, numbness 1
• Gait disturbances, ataxia 1
• Cognitive difficulties, memory problems 1
• Glossitis or tongue symptoms 1

Patients WITHOUT Neurological Symptoms

Hydroxocobalamin 1 mg intramuscularly three times weekly for 2 weeks, followed by maintenance of 1 mg IM every 2–3 months for life. 1, 4

Maintenance Therapy

The standard maintenance regimen is hydroxocobalamin 1 mg intramuscularly every 2–3 months for life. 1 Monthly dosing (1000 mcg IM monthly) is an acceptable alternative that may better meet metabolic requirements in patients with persistent symptoms, post-bariatric surgery status, or extensive ileal disease. 1

When to Increase Injection Frequency

• Recurrence of neurological symptoms 1
• Persistent fatigue despite "normal" serum B12 2
• Post-bariatric surgery patients with ongoing symptoms 1
• Extensive ileal resection (>20 cm) 1

Up to 50% of patients require individualized injection regimens ranging from daily, twice weekly, to every 2–4 weeks to remain symptom-free. 2 Titration should be based on clinical symptoms, not serum B12 or MMA levels. 2

Special Populations Requiring Lifelong Injections

Post-Bariatric Surgery

Hydroxocobalamin 1 mg IM every 3 months indefinitely, initiated immediately after surgery. 1 Alternative: oral B12 1000–2000 mcg daily, though IM is preferred for malabsorptive procedures (Roux-en-Y, biliopancreatic diversion). 1

Ileal Resection or Crohn's Disease

Patients with >20 cm distal ileum resected require prophylactic hydroxocobalamin 1000 mcg IM monthly for life, even without documented deficiency. 1 Those with ileal Crohn's involving >30–60 cm need annual screening and prophylactic supplementation. 1

Pernicious Anemia

Lifelong hydroxocobalamin 1 mg IM every 2–3 months after initial loading, as intrinsic factor deficiency is permanent. 1, 3

Critical Pitfalls to Avoid

Never administer folic acid before correcting B12 deficiency—folic acid can mask megaloblastic anemia while allowing irreversible subacute combined degeneration of the spinal cord to progress. 1, 3 Only after B12 repletion should folic acid 5 mg daily be added if folate deficiency is documented. 1

Never discontinue injections even if serum B12 normalizes—patients with malabsorption require lifelong therapy regardless of laboratory values. 1, 4 The underlying cause (pernicious anemia, bariatric surgery, ileal resection) is permanent. 1

Never rely solely on serum B12 to guide treatment—up to 50% of patients with "normal" serum B12 have metabolic deficiency when MMA is measured. 3 Clinical response and functional biomarkers (homocysteine, MMA) are more reliable. 1, 3

Formulation Selection

Hydroxocobalamin is the preferred injectable form due to superior tissue retention and established dosing protocols across all major guidelines. 1

In patients with renal dysfunction (eGFR <50 mL/min), use hydroxocobalamin or methylcobalamin instead of cyanocobalamin—cyanocobalamin requires renal clearance of cyanide metabolites and is associated with doubled cardiovascular risk (HR 2.0) in diabetic nephropathy. 1

Monitoring Schedule

• First year: Check serum B12, homocysteine, and MMA at 3,6, and 12 months 1
• After stabilization: Annual monitoring of B12, homocysteine, and complete blood count 1
• Post-bariatric surgery patients planning pregnancy: Every 3 months 1

Monitor for neurological symptom improvement rather than laboratory values—clinical response is the primary endpoint. 1, 2 Pain and paresthesias typically improve before motor symptoms. 1

Oral vs. Intramuscular Therapy

Intramuscular therapy is mandatory for:

• Severe neurological involvement (faster clinical improvement) 1
• Post-bariatric surgery (especially Roux-en-Y, biliopancreatic diversion) 1
• Pernicious anemia with positive intrinsic factor antibodies 1, 3
• Ileal resection >20 cm 1
• Failed oral therapy 1

Oral B12 (1000–2000 mcg daily) may be considered for dietary deficiency without malabsorption, though evidence for long-term efficacy in replacing injections is lacking. 2 Doses of 647–1032 mcg daily are required to normalize mild deficiency—more than 200 times the RDA. 5